plasmodium
falciparum
erythrocyt
invas
multistep
process
involv
spectrum
interact
well
character
character
immunogen
protein
possess
coiledcoil
structur
protein
local
surfac
merozoit
gametocyt
henc
name
plasmodium
falciparum
surfacerel
antigen
pfsra
process
fragment
pfsra
bind
normal
human
erythrocyt
differ
sensit
enzym
treatment
tempor
imag
initi
attach
intern
viabl
merozoit
reveal
fragment
pfsra
along
intern
invas
moreov
parasit
growth
inhibit
assay
show
pfsra
antibodi
potent
inhibit
erythrocyt
invas
sialic
aciddepend
independ
parasit
strain
also
immunoepidemiolog
studi
show
malariainfect
popul
natur
acquir
antibodi
pfsra
overal
result
demonstr
pfsra
structur
function
characterist
promis
target
vaccin
develop
malaria
deadli
infecti
diseas
affect
inhabit
tropic
subtrop
region
world
account
approxim
million
case
death
annual
clinic
manifest
diseas
begin
blood
stage
infect
parasit
invad
human
erythrocyt
plasmodium
falciparum
erythrocyt
invas
complic
process
involv
array
receptorligand
interact
andor
proteinprotein
interact
occur
parasitehost
cell
interfac
facilit
recruit
parasit
invas
machineri
thu
recent
identif
p
falciparum
surfac
protein
access
humor
cellular
immun
system
major
advanc
toward
vaccin
develop
malaria
given
great
impetu
idea
multiantigen
vaccin
intervent
strategi
bloodstag
malaria
therefor
select
priorit
candid
antigen
critic
aspect
strategi
although
sever
bloodstag
antigen
extens
studi
demonstr
desir
qualiti
vaccin
candid
one
remark
observ
p
falciparum
genom
sequenc
project
nearli
parasit
gene
lack
sequenc
similar
gene
known
organ
thu
gene
remain
hypothet
defin
function
role
subsequ
avail
comprehens
genom
proteom
transcriptom
dataset
human
plasmodium
pave
way
character
hypothet
protein
use
informaticsbas
approach
requir
success
identif
repertoir
novel
p
falciparum
merozoit
antigen
could
explor
target
ration
vaccin
design
detail
understand
function
role
p
falciparum
novel
merozoit
antigen
local
fate
invas
critic
identif
target
host
immun
priorit
merozoit
antigen
inclus
bloodstag
malaria
vaccin
herein
identifi
novel
p
falciparum
protein
plasmodb
id
name
p
falciparum
surfacerel
antigen
pfsra
base
dual
subcellular
local
merozoit
gametocyt
nativ
pfsra
proteolyt
process
multipl
fragment
parasit
cultur
supernat
fragment
pfsra
exhibit
erythrocytebind
activ
import
antibodi
pfsra
potent
inhibit
merozoit
invas
erythrocyt
sialic
aciddepend
sialic
acidindepend
parasit
strain
data
also
demonstr
pfsra
target
natur
acquir
immun
respons
human
identifi
new
bloodstag
protein
potenti
vaccin
candid
systemat
screen
procedur
implement
includ
analysi
tempor
gene
express
rel
wellcharacter
invasiontyp
gene
silico
interrog
protein
structur
featur
select
criteria
ascertain
sequenc
align
analysi
done
evalu
conserv
level
target
gene
across
differ
plasmodium
speci
ortholog
final
scan
entir
protein
sequenc
use
current
stateoftheart
onlin
thread
program
identifi
coiledcoil
region
three
synthet
peptid
correspond
immunogen
epitop
synthes
genescript
basi
harbor
coiledcoil
signatur
correspond
conserv
region
pfsra
ortholog
ethic
approv
obtain
ethic
committe
document
previous
immunoreact
screen
plasma
sampl
perform
enzymelink
immunosorb
assay
elisa
immunodot
blot
use
synthet
peptid
pfsra
nnkdnhnkkdtnenc
pfsra
cendndeygnknkn
pfsra
csnnkkkkk
ndkkkk
peptid
lfskfgsrmhilkc
use
control
peptid
block
ama
interact
naiv
plasma
use
neg
control
ctermin
human
antibodi
affinitypurifi
plasma
sampl
malariaexpos
children
describ
previous
plasmodium
falciparum
strain
maintain
cultur
describ
previous
schizont
purifi
use
percollalanin
gradient
centrifug
follow
saponin
lysi
recov
parasit
pellet
lyse
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sampl
buffer
parasit
cultur
supernat
ringstag
invas
supernat
use
sourc
nativ
pfsra
detect
immunoblot
use
primari
antibodi
peptid
immunoblot
develop
use
goat
horseradish
peroxidaseconjug
secondari
antibodi
enhanc
chemiluminesc
reagent
thermo
scientif
erythrocytebind
assay
eba
perform
use
parasit
cultur
supernat
describ
previous
immunofluoresc
microscopi
carri
use
p
falciparum
infect
erythrocyt
smear
onto
glass
slide
fix
prechil
methanol
minut
fix
erythrocyt
permeabil
use
triton
formul
phosphatebuff
salin
nonpermeabil
liquid
immunofluoresc
assay
ifa
carri
describ
previous
wash
step
ifa
condit
slide
block
hour
pb
contain
bovin
serum
albumin
slide
probe
primari
secondari
antibodi
respect
antigen
mount
vectashield
vector
laboratori
inc
supplement
stain
nucleu
fluoresc
microscopi
perform
olympu
fluoresc
microscop
imag
captur
process
use
open
access
fijiimag
j
softwar
nation
institut
health
test
intern
antibodi
polyclon
antibodi
incub
tightli
synchron
segment
schizont
allow
ruptur
releas
merozoit
viabil
releas
merozoit
assess
differ
stage
earli
mid
late
invad
merozoit
stage
smear
prepar
fix
examin
immunofluoresc
microscopi
describ
growth
inhibit
assay
gia
perform
describ
previous
parasitemia
level
determin
use
flow
cytometri
bd
fortessa
flo
j
softwar
erythrocyt
invas
inhibitori
effect
antibodi
estim
comparison
percentag
invas
control
test
assay
systemat
screen
uncharacter
p
falciparum
protein
potenti
bloodstag
vaccin
candid
perform
datamin
analysi
gene
peak
mrna
express
level
late
schizogoni
use
data
p
falciparum
transcriptom
studi
anoth
studi
predict
proteas
specif
detail
analys
describ
supplementari
materi
supplementari
figur
overal
pfsra
emerg
top
hit
signal
peptid
predict
glycosylphosphatidylinositol
attach
site
furthermor
gener
sequenc
align
ortholog
pfsra
show
cterminu
pfsra
posit
conserv
cystein
residu
across
differ
plasmodium
speci
ortholog
supplementari
figur
addit
predict
analysi
psipr
reveal
pfsra
protein
sequenc
harbor
coiledcoil
signatur
supplementari
figur
signatur
form
stabl
structur
elicit
function
antibodi
consid
basi
design
pfsra
chemic
synthes
peptid
use
antibodi
gener
despit
sever
optim
procedur
express
escherichia
coli
attempt
express
recombin
pfsra
protein
unsuccess
howev
design
peptid
synthesi
correspond
conserv
region
pfsra
plasmodium
speci
ortholog
figur
pfsraderiv
peptid
pfsra
pfsra
pfsra
includ
coiledcoil
signatur
supplementari
figur
immun
rabbit
synthet
peptid
pfsra
pfsra
pfsra
genescript
result
high
titer
pfsra
peptidespecif
antibodi
use
subsequ
experi
preimmun
sera
use
immunoblot
neg
control
detect
nativ
pfsra
expect
antibodi
detect
nativ
reduc
condit
figur
antibodi
consist
detect
multipl
process
fragment
kda
nativ
pfsra
ringstag
invas
supernat
figur
iiv
parasit
cultur
supernat
figur
iiv
schizont
lysat
figur
iiv
identifi
fragment
pfsra
possess
erythrocytebind
activ
perform
erythrocyt
bind
assay
fragment
pfsra
clearli
detect
eluat
suggest
bound
erythrocyt
higher
exposur
fulllength
pfsra
process
fragment
also
detect
supplementari
figur
suggest
weaker
bind
rel
fragment
interest
bind
sensit
neuraminidas
trypsin
treatment
resist
chymotrypsin
treatment
figur
control
recombin
bound
erythrocyt
sensit
enzym
treatment
figur
stagespecif
express
analysi
p
falciparum
asexu
stage
ifa
show
peptid
antibodi
label
surfac
membran
merozoit
intact
schizont
releas
merozoit
respect
figur
c
howev
antibodi
label
develop
ringstag
parasit
serv
use
intern
control
subsequ
experi
asexu
stage
colabel
segment
ruptur
schizont
releas
merozoit
antibodi
micronem
marker
show
coloc
figur
even
though
report
exist
circumferenti
stain
pattern
howev
antibodi
antibodi
coloc
parasitophor
vacuol
late
trophozoit
segment
schizont
releas
merozoit
figur
segment
schizont
releas
merozoit
protein
coloc
merozoit
surfac
figur
liquid
ifa
show
antibodi
antibodi
label
surfac
nonpermeabil
merozoit
figur
control
panel
show
label
invad
merozoit
permeabil
condit
label
observ
antibodi
figur
determin
fate
nativ
pfsra
invas
invad
merozoit
differ
timepoint
earli
mid
late
postinvas
colabel
antibodi
observ
label
antibodi
time
point
invas
figur
suggest
fragment
unprocess
form
pfsra
carri
erythrocyt
invas
control
latestag
parasit
intern
merozoit
colabel
gametocyt
surfac
marker
antibodi
wherea
antibodi
label
intern
merozoit
label
observ
antibodi
figur
panel
plasma
sampl
malariainfect
children
resid
malariaendem
site
ghana
accra
navrongo
kintampo
evalu
reactiv
pfsra
synthet
peptid
elisa
plasma
antibodi
children
accra
navrongo
show
reactiv
peptid
beyond
background
normal
human
serum
nh
level
wherea
kintampo
slightli
background
howev
differ
statist
signific
p
figur
plasma
sampl
site
appear
recogn
pfsra
peptid
group
show
reactiv
background
level
figur
statist
differ
reactiv
pfsra
signific
compar
nh
plasma
navrongo
p
accra
p
kintampo
figur
reactiv
pfsra
signific
compar
nh
plasma
kintampo
p
accra
p
navrongo
figur
howev
reactiv
pfsra
signific
site
kintampo
p
navrongo
p
accra
p
figur
preimmun
pfsra
possess
signal
peptid
predict
glycosylphosphatidylinositol
gpi
anchor
repres
cleavag
site
analyz
predict
proteas
specif
tool
repres
gpitransamidas
cleavag
site
predict
gpi
attach
signal
pfsra
pfsra
pfsra
design
conserv
region
pfsra
differ
ortholog
possess
coiledcoil
signatur
chemic
synthes
peptid
design
c
design
carboxyl
terminu
n
design
amino
terminu
b
antibodi
detect
multipl
process
fragment
nativ
pfsra
immunoblot
ringstag
invas
supernat
iss
probe
mous
antibodi
rabbit
antibodi
lot
ii
antibodi
lot
iii
antibodi
lot
iv
color
bar
far
right
repres
predict
process
fragment
kda
v
c
antipfsra
antibodi
detect
multipl
process
fragment
nativ
pfsra
immunoblot
parasit
cultur
supernat
css
probe
preimmun
sera
antibodi
ii
antibodi
iii
pfsra
antibodi
iv
antipfsra
antibodi
detect
multipl
process
fragment
nativ
pfsra
immunoblot
schizont
lysat
sl
probe
preimmun
sera
antibodi
ii
antibodi
iii
antibodi
iv
e
color
bar
far
right
repres
predict
process
fragment
kda
v
f
recombin
use
control
bound
erythrocyt
neuraminidasesensit
trypsinsensit
chymotrypsinresist
manner
similarli
process
fragment
nativ
pfsra
bound
erythrocyt
neuraminidasesensit
trypsinsensit
chymotrypsinresist
manner
abbrevi
ct
chymotrypsin
gh
normal
human
erythrocyt
ghost
nt
neuraminidas
tt
trypsin
ut
untreat
control
consist
elisa
data
also
establish
immunodot
blot
plasma
sampl
malariainfect
children
recogn
pfsra
figur
thu
human
antibodi
cterminu
protein
purifi
pool
sampl
plasma
kintampo
children
show
immunoreact
figur
consist
data
rabbit
antibodi
figur
human
immunoaffin
purifi
antibodi
stain
schizont
releas
merozoit
coloc
antibodi
merozoit
surfac
figur
perform
stagespecif
express
analysi
gametocyt
stage
iiiv
microscopi
observ
antibodi
specif
label
membran
gametocyt
wherea
control
antibodi
label
gametocyt
figur
stage
iiv
respect
peptid
antibodi
gametocyt
surfac
marker
antibodi
show
close
coloc
appear
stagedepend
figur
furthermor
pfsra
express
gametocyt
appear
sexspecif
antibodi
label
male
femal
gametocyt
antibodi
label
male
gametocyt
supplementari
figur
evalu
invas
inhibitori
activ
antibodi
p
falciparum
show
pfsra
peptid
antibodi
exhibit
inhibit
wherea
preimmun
control
show
inhibit
supplementari
figur
pfsra
peptid
antibodi
inhibitori
higher
concentr
supplementari
figur
shown
wherea
preimmun
sera
control
immunoglobulin
g
igg
inhibit
parasit
invas
lower
concentr
antibodi
exhibit
concentrationdepend
inhibit
parasit
invas
figur
pfsra
peptid
antibodi
test
antibodi
show
inhibit
parasit
invas
control
antibasigin
antibodi
show
inhibit
parasit
invas
figur
exclud
possibl
serum
contamin
might
interf
parasit
invas
gener
antibodi
shorter
construct
use
purif
procedur
peptidespecif
antibodi
inhibit
parasit
invas
observ
figur
antibodi
inhibitori
test
combin
peptid
antibodi
observ
strategi
greatli
impact
parasit
invas
inhibit
figur
furthermor
perform
invas
inhibit
assay
ghanaian
clinic
isol
observ
similar
pattern
parasit
invas
inhibit
peptid
antibodi
figur
focu
work
identif
function
character
potenti
bloodstag
malaria
vaccin
candid
pfsra
use
bioinformat
datamin
analysi
publish
p
falciparum
transcriptom
proteom
identifi
pfsra
reminisc
surfac
protein
defin
presenc
signal
peptid
predict
glycosylphosphatidylinositol
attach
signal
inde
pfsra
shown
cleavag
site
assign
use
predict
proteas
specif
analysi
platform
presenc
proteolyt
cleavag
site
pfsra
may
allud
process
event
occur
prior
invas
erythrocyt
besid
proteolyt
process
malaria
parasit
shown
relev
cascad
interact
occur
parasitehost
cell
interfac
furthermor
ortholog
good
candid
multispeci
vaccin
gener
sequenc
align
pfsra
ortholog
show
cterminu
pfsra
posit
conserv
cystein
residu
across
differ
speci
ortholog
attempt
express
recombin
pfsra
possess
unstructur
region
unsuccess
similarli
other
attempt
express
matur
recombin
pfsra
cell
use
codonoptim
gene
geneart
also
unsuccess
consid
pfsra
asparaginerich
protein
numer
potenti
nlink
glycosyl
site
attempt
express
insect
cell
system
produc
protein
complex
nlink
glycosyl
may
present
relev
sugar
epitop
nativ
glycosyl
therefor
challeng
associ
express
recombin
pfsra
necessit
design
chemic
synthet
peptid
epitopebas
vaccin
strategi
plasmodium
falciparum
surfacerel
antigen
harbor
coiledcoil
domain
known
less
polymorph
form
stabl
structur
elicit
function
antibodi
block
relev
domain
mani
organ
interestingli
domain
evalu
potenti
target
peptidebas
vaccin
pfsra
peptid
antibodi
rabbit
specif
detect
breakdown
product
nativ
pfsra
ringstag
invas
supernat
parasit
cultur
supernat
schizont
lysat
indic
pfsra
synthet
peptid
antigen
mimic
nativ
parasit
protein
data
show
pfsra
postsynthet
process
cleavag
parasit
cultur
supernat
consist
cleavag
site
harbor
merozoit
surfac
remodel
seri
proteolyt
process
event
physiolog
relev
event
malaria
parasit
remain
poorli
describ
howev
report
suggest
proteolyt
process
may
result
activ
structur
rearrang
acquisit
new
function
properti
nativ
parasit
protein
describ
fate
shed
pattern
nativ
pfsra
tempor
immunofluoresc
imag
use
antibodi
bound
merozoit
surfac
intern
erythrocyt
invas
consist
observ
previou
report
antibodi
carri
invad
erythrocyt
disrupt
intraerythrocyt
develop
inhibit
erythrocyt
invas
although
molecular
mechan
underli
intern
antibodi
remain
debat
suggest
tight
junction
merozoit
erythrocyt
might
consist
transient
interact
allow
passag
antibodi
surfac
protein
peptid
antibodi
recogn
differ
pfsra
polypeptid
fragment
ringstag
invas
supernat
parasit
cultur
supernat
schizont
lysat
vari
threshold
expedi
investig
whether
process
could
influenc
differenti
subcellular
local
pfsra
parasit
interestingli
rabbit
peptid
antibodi
show
circumferenti
associ
merozoit
surfac
time
schizont
ruptur
merozoit
releas
similarli
perform
colabel
ifa
gametocyt
stage
iiv
use
rabbit
peptid
antibodi
gametocyt
surfac
marker
clear
punctat
rimfluoresc
pattern
observ
rabbit
peptid
antibodi
appear
coloc
stagedepend
manner
base
coloc
coeffici
therefor
consist
stain
pattern
rabbit
peptid
antibodi
asexu
gametocyt
stage
suggest
proteolyt
process
pfsra
caus
chang
subcellular
local
protein
although
distribut
protein
male
femal
gametocyt
could
link
function
diverg
sex
observ
express
pfsra
male
femal
gametocyt
consist
observ
exist
report
plasmodium
berghei
gametocyt
egress
sporozoit
travers
protein
pbgest
express
sex
also
imper
determin
whether
pfsra
releas
merozoit
access
humor
immun
surveil
short
period
erythrocyt
invas
serolog
screen
buttress
immunodot
blot
assay
plasma
sampl
malariainfect
children
resid
differ
endem
site
show
differ
total
igg
recognit
frequenc
pfsra
peptid
could
link
vari
transmiss
intens
rate
report
sampl
collect
differ
endem
site
previou
studi
case
reactiv
pfsra
synthet
peptid
low
like
explan
could
hinder
access
pfsra
nativ
context
howev
data
ifa
show
immunoaffin
purifi
human
peptid
antibodi
label
nativ
pfsra
suggest
malariainfect
popul
natur
acquir
antibodi
pfsra
gener
sever
receptor
character
base
sensit
differ
enzym
treatment
notabl
neuraminidas
remov
sialic
acid
glycophorin
trypsin
cleav
peptid
backbon
sever
receptor
glycophorin
glycophorin
c
complement
receptor
chymotrypsin
cleav
glycophorin
b
complement
receptor
among
other
shown
fragment
nativ
pfsra
bind
normal
human
erythrocyt
molecular
ident
receptor
remain
unknown
howev
classifi
put
receptor
pfsra
sialic
aciddepend
basi
bind
specif
sensit
treatment
neuraminidas
trypsin
resist
chymotrypsin
bind
phenotyp
fit
descript
receptor
glycophorin
c
enzym
sensit
profil
pfsra
bind
erythrocyt
similar
observ
region
ii
parasit
ligand
glycophorin
c
addit
investig
requir
determin
whether
pfsra
also
interact
glycophorin
c
possibl
via
differ
bind
site
data
reveal
pfsra
peptid
induc
function
antibodi
inhibit
p
falciparum
erythrocyt
invas
laboratori
strain
clinic
isol
observ
invas
inhibitori
activ
rabbit
peptid
antibodi
could
attribut
indirect
effect
antibodi
bind
merozoit
surfac
direct
inhibit
proteolyt
process
event
demonstr
pfsra
synthet
peptid
induc
erythrocyt
invas
inhibitori
antibodi
success
purif
limit
amount
pfsraspecif
human
antibodi
patient
plasma
suggest
synthet
peptid
possess
structur
integr
conform
mimic
nativ
pfsra
summari
studi
provid
relev
new
inform
regard
proteolyt
process
pfsra
support
idea
target
cleavag
event
develop
antimalari
therapi
express
pfsra
late
stage
gametocyt
unpreced
opportun
explor
potenti
transmissionblock
vaccin
also
pfsraspecif
immun
respons
trigger
natur
infect
may
inform
inclus
pfsra
candid
epitopebas
bloodstag
malaria
vaccin
develop
